Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yada Kanjanapan

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer Medicine|November 7, 2020
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapyYada Kanjanapan, Desmond Yip
BMJ Case Reports|May 23, 2020
Acute ischaemic stroke following cisplatin-based chemotherapy for testicular cancerYada Kanjanapan, Daniel Gilbourd, Ganesalingam Pranavan
Expert Opinion on Pharmacotherapy|March 17, 2017
Niraparib for the treatment of ovarian cancerYada Kanjanapan, Stephanie Lheureux, Amit M Oza
Internal Medicine Journal|June 22, 2021
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumoursYada Kanjanapan, Prunella Blinman, Craig Underhill, et al.
Clinical Breast Cancer|September 18, 2024
Real-World Analysis of Breast Cancer Patients Qualifying for Adjuvant CDK4/6 InhibitorsYada Kanjanapan, Wayne Anderson, Mirka Smith, et al.
Journal of Gastrointestinal Oncology|January 16, 2025
Cancer metastasis to the upper gastrointestinal tract-a case seriesMohamed Bakry, Hasib Ahmadzai, Mitali Fadia, et al.
Technology in Cancer Research & Treatment|October 27, 2023
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World SettingYada Kanjanapan, Geetha Guduguntla, Ashwati Krishnan Varikara, et al.
Clinical and Translational Radiation Oncology|April 17, 2018
Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiationYada Kanjanapan, Siddhartha Deb, Richard J Young, et al.
Plos One|June 11, 2021
Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapyMorven Cunningham, Marco Iafolla, Yada Kanjanapan, et al.
BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Medicine|November 7, 2020
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapyYada Kanjanapan, Desmond Yip
BMJ Case Reports|May 23, 2020
Acute ischaemic stroke following cisplatin-based chemotherapy for testicular cancerYada Kanjanapan, Daniel Gilbourd, Ganesalingam Pranavan
Expert Opinion on Pharmacotherapy|March 17, 2017
Niraparib for the treatment of ovarian cancerYada Kanjanapan, Stephanie Lheureux, Amit M Oza
Internal Medicine Journal|June 22, 2021
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumoursYada Kanjanapan, Prunella Blinman, Craig Underhill, et al.
Clinical Breast Cancer|September 18, 2024
Real-World Analysis of Breast Cancer Patients Qualifying for Adjuvant CDK4/6 InhibitorsYada Kanjanapan, Wayne Anderson, Mirka Smith, et al.
Journal of Gastrointestinal Oncology|January 16, 2025
Cancer metastasis to the upper gastrointestinal tract-a case seriesMohamed Bakry, Hasib Ahmadzai, Mitali Fadia, et al.
Technology in Cancer Research & Treatment|October 27, 2023
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World SettingYada Kanjanapan, Geetha Guduguntla, Ashwati Krishnan Varikara, et al.
Clinical and Translational Radiation Oncology|April 17, 2018
Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiationYada Kanjanapan, Siddhartha Deb, Richard J Young, et al.
Plos One|June 11, 2021
Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapyMorven Cunningham, Marco Iafolla, Yada Kanjanapan, et al.
BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.
Pageof 3